Skip to content

Differences in Urine NGAL Levels in Patients Undergoing RIRS With or Without Ureteral Access Sheath

Differences in Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels in Patients Undergoing Retrograde Intrarenal Surgery (RIRS) With or Without Ureteral Access Sheath (UAS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02485002
Enrollment
60
Registered
2015-06-30
Start date
2015-06-30
Completion date
2016-03-31
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

kidney, kidney stone, NGAL, ureterorenoscopy, intrarenal surgery, kidney function

Brief summary

This study will include patients aged between 18 and 65 who will undergo retrograde infrarenal surgery (RIRS) due to renal stone(s). A total of 60 patients (male or female) will be recruited, and will be randomized into 2 groups consisting of 30 patients in each group. The first group of patients will undergo RIRS with a ureteral access sheath (UAS) positioned prior to surgery; and the second group will undergo RIRS without UAS. As use of UAS decreases the pressure in the renal pelvis during RIRS, it is aimed to evaluate whether using UAS or not affects the kidney functions. besides the routine kidney function tests, namely urea and creatinine, neutrophil gelatinase-associated lipocalin (NGAL) (a more specific and early marker of kidney function) will be used to assess the differences in the kidney functions. Preoperative blood urea and creatinine levels and urine NGAL levels will be studied for all patients. After the surgery, blood urea and creatinine levels will be again studied as well as urine NGAL levels at postoperative 2nd hour, 72nd hour and 1st week.

Interventions

Ureteral access sheath will be used during RIRS.

Ureteral access sheath will not be used during RIRS.

Sponsors

Selcuk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being between 18-65 years old * Having an indication of retrograde infrarenal surgery (RIRS) due to kidney stone

Exclusion criteria

* Patients with uncontrolled diabetes mellitus and diabetic nephropathy * Patients with blood pressure \> 140/80 mmHg despite regular use of antihypertensive agent(s) * Patients with chronic kidney failure who need dialysis * Patients who have had prerenal, renal or postrenal acute kidney failure 3 months or much earlier * Patients who have had pyelonephritis 3 months or much earlier * Patients younger than 18 years or older than 65 years * Patients who have undergone a kidney surgery within the last 3 months and have abnormal kidney function tests * Patients with a concomitant ureter stone who will undergo an endoscopic ureter stone treatment at the same session

Design outcomes

Primary

MeasureTime frameDescription
Urine NGAL level (ng/mL)Within the first 7 days after surgery (RIRS)Determination of any impairment in renal function when ureteral access sheath is not used during RIRS by measuring urine NGAL level.

Secondary

MeasureTime frameDescription
Blood urea level (mg/dL) and creatinine level (mg/dL)Within the first 7 days after surgery (RIRS)Determination of any impairment in renal function when ureteral access sheath is not used during RIRS by measuring blood urea and creatinine levels.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026